CHF: a novel factor binding to cyclin A CHR corepressor element.

Abstract:

:Cell cycle modulation of cyclin A expression is due to the periodic relief of a transcriptional repression mediated by a bipartite negative DNA regulatory region. The 5' element (Cell Cycle Responsive Element: CCRE; cell Cycle Dependent Element: CDE) is clearly occupied in a cyclic manner in vivo, whereas the 3' element, whose sequence is shared by B-myb, cdc25C and cdc2 genes (cell Cycle gene Homology Region: CHR), is involved in more subtle interactions. Mutation of either element results in complete deregulation of cyclin A promoter activity. Whereas some reports claim that E2F/DP can bind to the CCRE/CDE, the nature of the protein(s) interacting with the CHR is unknown. In the present work we have characterized an activity present in quiescent cells and absent in cells blocked in S phase, which binds specifically to cyclin A CHR, but not to B-myb, or to cdc25C, or to cdc2 CHRs. A 90 kD protein, named CHF (cyclin A CHR binding factor), has been identified through preparative electrophoresis and UV crosslinking experiments. In order to address in more functional terms the binding of CHF to cyclin A CHR, we developed in vitro and in vivo oligonucleotide competition assays. Both in vitro transcription and in vivo microinjection experiments demonstrate that a functional difference exists between the composite CCRE/CDE-CHR repressor regions of cell cycle regulated genes such as cyclin A and cdc25C.

journal_name

Oncogene

journal_title

Oncogene

authors

Philips A,Chambeyron S,Lamb N,Vié A,Blanchard JM

doi

10.1038/sj.onc.1203017

subject

Has Abstract

pub_date

1999-11-04 00:00:00

pages

6222-32

issue

46

eissn

0950-9232

issn

1476-5594

journal_volume

18

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation.

    abstract::Expression of oncogenic H-Ras in 23A2 myoblasts (A2:H-Ras cells) is sufficient to induce both a transformed phenotype and a differentiation-defective phenotype. Because oncogenic Ras is known to induce the secretion of several different growth factors involved in maintaining the transformed phenotype of both fibroblas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201423

    authors: Weyman CM,Wolfman A

    更新日期:1997-11-20 00:00:00

  • Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.

    abstract::We have shown earlier that the IFN-beta and all-trans retinoic acid (RA) combination, but not the single agents, induces death in several tumor cell lines. Employing a genetic technique we have identified several Genes associated with Retinoid-IFN induced Mortality (GRIM). One of the GRIMs was human thioredoxin reduct...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204585

    authors: Hu J,Ma X,Lindner DJ,Karra S,Hofmann ER,Reddy SP,Kalvakolanu DV

    更新日期:2001-07-12 00:00:00

  • The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.

    abstract::Small cell lung cancer (SCLC) is a disease characterized by aggressive clinical behavior and lack of effective therapy. Owing to its tendency for early dissemination, only a third of patients have limited-stage disease at the time of diagnosis. SCLC is thought to derive from pulmonary neuroendocrine cells. Although se...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.362

    authors: Kalari S,Jung M,Kernstine KH,Takahashi T,Pfeifer GP

    更新日期:2013-07-25 00:00:00

  • The FHIT gene is alternatively spliced in normal kidney and renal cell carcinoma.

    abstract::FHIT (Fragile Histidine Triad), a putative tumor suppressor gene, was cloned from fetal brain and colon cDNA libraries. Portions of this gene are deleted in esophageal, colon, lung and breast tumors, but this gene has not been found altered in sporadic renal cell carcinomas. We report here an alternatively spliced for...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201164

    authors: Luan X,Shi G,Zohouri M,Paradee W,Smith DI,Decker HJ,Cannizzaro LA

    更新日期:1997-07-03 00:00:00

  • p53-dependent downregulation of metastasis-associated laminin receptor.

    abstract::Based on observations suggesting a role for the tumor suppressor protein p53 in regulating expression of the 67-kDa laminin receptor precursor, 37LRP, we analysed the 37LRP promoter activity in a wild-type p53 (wt p53) ovarian carcinoma cell line and in a cisplatin-resistant subline with mutated p53. We observed an in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205957

    authors: Modugno M,Tagliabue E,Ardini E,Berno V,Galmozzi E,De Bortoli M,Castronovo V,Ménard S

    更新日期:2002-10-24 00:00:00

  • Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.

    abstract::Heregulins are a group of growth factors that play diverse and critical roles in the signaling network of the human epidermal growth factor receptor (HER or EGFR) superfamily. Our earlier studies have shown that recombinant heregulinbeta1 (HRG) induces apoptosis in SKBr3 breast cancer cells that overexpress HER2. Here...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205039

    authors: Le XF,Marcelli M,McWatters A,Nan B,Mills GB,O'Brian CA,Bast RC Jr

    更新日期:2001-12-13 00:00:00

  • Interaction of HTLV-1 Tax and methyl-CpG-binding domain 2 positively regulates the gene expression from the hypermethylated LTR.

    abstract::Epigenetic regulation of gene expression is critical in the maintenance of cellular homeostasis. Dysregulation of normal epigenetic transcription occurs in abnormal physiological conditions, such as those seen in cancer cells and cells infected with parasites, making the mechanism underlying abnormal epigenetic transc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208394

    authors: Ego T,Tanaka Y,Shimotohno K

    更新日期:2005-03-10 00:00:00

  • Medullary thyroid carcinomas in transgenic mice expressing a Polyoma carboxyl-terminal truncated middle-T and wild type small-T antigens.

    abstract::Medullary thyroid carcinoma (MTC) is a rare human tumor affecting the calcitonin-secreting c-cells of the thyroid. Here we report that two independent strains of transgenic mice expressing a Polyomavirus (Py) truncated middle-T antigen (deltaMT), consisting of the amino-terminal 304 amino acids, and the full length Py...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202578

    authors: Felici A,Giorgio M,Krauzewicz N,Della Rocca C,Santoro M,Rovere P,Manni I,Amati P,Pozzi L

    更新日期:1999-04-08 00:00:00

  • Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells.

    abstract::Stimulation of resting W53 cells (lymphoid murine cells expressing prolactin (PRL) receptor) by PRL induced expression of growth-related immediate-early genes (IEG), and proliferation through activation of the Src kinases. Since IEG are essential for cell cycle progression, we have studied how PRL controls expression ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208002

    authors: Domínguez-Cáceres MA,García-Martínez JM,Calcabrini A,González L,Porque PG,León J,Martín-Pérez J

    更新日期:2004-09-23 00:00:00

  • FOXA1 inhibits prostate cancer neuroendocrine differentiation.

    abstract::Neuroendocrine prostate cancer (NEPC) has increasingly become a clinical challenge. The mechanisms by which neuroendocrine (NE) cells arises from prostate adenocarcinoma cells are poorly understood. FOXA1 is a transcription factor of the forkhead family that is required for prostate epithelial differentiation. In this...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.50

    authors: Kim J,Jin H,Zhao JC,Yang YA,Li Y,Yang X,Dong X,Yu J

    更新日期:2017-07-13 00:00:00

  • Inhibition of crystallin expression and induction of apoptosis by lens-specific E1A expression in transgenic mice.

    abstract::Previous studies have shown that the adenovirus E1A oncoprotein can bind to and inactivate the retinoblastoma tumor suppressor protein (pRb) and the transcriptional coactivators CBP/p300. In this study, wild-type E1A12S or two deletion mutants (delN, which binds pRb but not CBP/p300; delCR2, which binds to CBP/p300 bu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205050

    authors: Chen Q,Ash JD,Branton P,Fromm L,Overbeek PA

    更新日期:2002-02-07 00:00:00

  • EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms.

    abstract::Amplification and rearrangements of the epidermal growth factor receptor (EGFR) gene are frequently found in glioblastoma multiforme (GBM). The most common variant is EGFR variant III (EGFRvIII). Research suggests that EGFRvIII could be a marker for a cancer stem cell or tumor-initiating population. If amplification a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.280

    authors: Del Vecchio CA,Giacomini CP,Vogel H,Jensen KC,Florio T,Merlo A,Pollack JR,Wong AJ

    更新日期:2013-05-23 00:00:00

  • The human papillomavirus type 16 (HPV-16) E5 protein sensitizes human keratinocytes to apoptosis induced by osmotic stress.

    abstract::We have studied the role of the HPV-16 E5 protein in apoptosis, using HaCaT cell lines stably transfected with either E5 (HaCaT/E5) or the empty vector (HaCaT/pMSG) as control. When subjected to a hyperosmolar concentration of sorbitol, HaCaT/E5 cells respond with cytochrome c release, activation of caspase-3, -8, and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205147

    authors: Kabsch K,Alonso A

    更新日期:2002-01-31 00:00:00

  • HER2/Neu: mechanisms of dimerization/oligomerization.

    abstract::DOI: 10.1038/sj/onc/1205119 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205119

    authors: Brennan PJ,Kumagai T,Berezov A,Murali R,Greene MI

    更新日期:2002-01-10 00:00:00

  • The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus.

    abstract::BPV-4 E5 inhibits transcription of the bovine MHC class I heavy chain (HC) gene, increases degradation of HC and downregulates surface expression of MHC class I by retaining the complex in the Golgi apparatus (GA). Here we report that transcription inhibition can be alleviated by interferon treatment and the degradati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209245

    authors: Marchetti B,Ashrafi GH,Dornan ES,Araibi EH,Ellis SA,Campo MS

    更新日期:2006-04-06 00:00:00

  • Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.

    abstract::Ovarian cancer is the leading cause of death among all gynecological malignancies due to the development of acquired chemoresistance and disease relapse. Although the role of cancer stem cells (CSCs), a subset of tumor cells with the self-renewal and differentiation capabilities, in therapeutic resistance is beginning...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.320

    authors: Ramadoss S,Sen S,Ramachandran I,Roy S,Chaudhuri G,Farias-Eisner R

    更新日期:2017-03-01 00:00:00

  • Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model.

    abstract::We reconstituted a three-dimensional gastric carcinoma model similar to invasive gastric carcinoma tissue. This model consists of a human gastric carcinoma cell line, GCTM-1, a human fibroblast cell line, TIG-1-20, and transforming growth factor-beta (TGF-beta)-containing type I collagen gel. Using this model, we were...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207046

    authors: Kuga H,Morisaki T,Nakamura K,Onishi H,Noshiro H,Uchiyama A,Tanaka M,Katano M

    更新日期:2003-10-30 00:00:00

  • Inhibition of oxidative phosphorylation underlies the antiproliferative and proapoptotic effects of mofarotene (Ro 40-8757) in Burkitt's lymphoma cells.

    abstract::In the search for retinoids active against Burkitt's lymphoma (BL), we found that the arotinoid mofarotene (Ro 40-8757) induced strong antiproliferative and apoptotic responses in most established BL cell lines as well as in primary BL cells. Ro 40-8757-induced apoptosis is associated with mitochondrial membrane depol...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206060

    authors: Cariati R,Zancai P,Righetti E,Rizzo S,De Rossi A,Boiocchi M,Dolcetti R

    更新日期:2003-02-13 00:00:00

  • Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.

    abstract::Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome that includes pheochromocytoma. Germline mutations in RET are responsible for MEN 2 but the precise pathogenetic mechanisms of tumorigenesis are unknown. We have recently identified possible mechanisms of tumor formation in patients with MEN 2...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205133

    authors: Koch CA,Huang SC,Zhuang Z,Stolle C,Azumi N,Chrousos GP,Vortmeyer AO,Pacak K

    更新日期:2002-01-17 00:00:00

  • The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.

    abstract::A recent large multi-centre study convincingly confirmed previous observations that the SYT-SSX1 fusion type, compared to SYT-SSX2, of synovial sarcoma is associated with a worse clinical outcome. Apart from the clinical impact, this fact also suggests (1) that the SYT-SSX fusion gene may influence molecular mechanism...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205700

    authors: Xie Y,Skytting B,Nilsson G,Grimer RJ,Mangham CD,Fisher C,Shipley J,Bjerkehagen B,Myklebost O,Larsson O

    更新日期:2002-08-22 00:00:00

  • Mutations that abolish the ability of Ha-Ras to associate with Raf-1.

    abstract::Recent studies have revealed that Ras can associate physically with Raf. In the present study, we tested 34 mutants of Ha-Ras carrying substitution(s) in the region of residues 23-71 for their ability to associate with Raf-1. Mouse Ba/F3 cell lysates were incubated with each mutant Ras protein, in either the guanosine...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Shirouzu M,Koide H,Fujita-Yoshigaki J,Oshio H,Toyama Y,Yamasaki K,Fuhrman SA,Villafranca E,Kaziro Y,Yokoyama S

    更新日期:1994-08-01 00:00:00

  • Expression of the receptor tyrosine kinase substrate genes eps8 and eps15 during mouse development.

    abstract::Receptor tyrosine kinases (RTKs) control proliferation and differentiation through their ability to bind and/or phosphorylate intracellular substrates. The repertoire of substrates recruited by different RTK is largely overlapping. It is not clear, therefore, how a cell distinguishes among signals originating from dif...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Avantaggiato V,Torino A,Wong WT,Di Fiore PP,Simeone A

    更新日期:1995-09-21 00:00:00

  • Stable expression of intracellular Notch suppresses v-Src-induced transformation in avian neural cells.

    abstract::Understanding how disruption of differentiation contributes to the cancer cell phenotype is required to identify alterations essential for malignant transformation and provide experimental basis for their correction. We investigated whether primary quail neuroretina cells, transformed by a conditional v-Src mutant (QN...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210124

    authors: Mateos S,Amarir S,Laugier D,Marx M,Calothy G

    更新日期:2007-05-17 00:00:00

  • TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

    abstract::Transforming growth factor-beta (TGF-β) is a pleiotropic cytokine with the capability to act as tumour suppressor or tumour promoter depending on the cellular context. TGF-beta receptor type-2 (TGFBR2) is the ligand-binding receptor for all members of the TGF-β family. Data from mouse model experiments demonstrated th...

    journal_title:Oncogene

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/onc.2013.527

    authors: Busch S,Acar A,Magnusson Y,Gregersson P,Rydén L,Landberg G

    更新日期:2015-01-02 00:00:00

  • Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma.

    abstract::The epidermal growth factor (EGF)/EGF-receptor (ErbB1-4) family is involved in the biology of multiple myeloma (MM). In particular, ErbB-specific inhibitors induce strong apoptosis of myeloma cells (MMC) in vitro. To delineate the contribution of the 10 EGF-family ligands to the pathogenesis of MM, we have assessed th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209699

    authors: Mahtouk K,Cremer FW,Rème T,Jourdan M,Baudard M,Moreaux J,Requirand G,Fiol G,De Vos J,Moos M,Quittet P,Goldschmidt H,Rossi JF,Hose D,Klein B

    更新日期:2006-11-16 00:00:00

  • TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.

    abstract::Tumor suppressor p53 has been shown to repress expression of vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen and a key mediator of tumor angiogenesis. The p63 gene, recently identified as a p53-relative, encodes multiple isoforms with structural and functional similarities and differenc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205330

    authors: Senoo M,Matsumura Y,Habu S

    更新日期:2002-04-11 00:00:00

  • New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.

    abstract::Telomeres are stabilized, and telomeric DNA is replenished, by the action of the ribonucleoprotein reverse transcriptase telomerase. Telomere capping functions include the ability of telomeres to protect chromosome ends from cellular DNA-damage responses such as cell cycle arrest or apoptosis. This property of telomer...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205082

    authors: Chan SW,Blackburn EH

    更新日期:2002-01-21 00:00:00

  • Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle.

    abstract::The mouse int6 gene is a frequent integration site of the mouse mammary tumor virus and INT6 silencing by RNA interference in HeLa cells causes an increased number of cells in the G2/M phases of the cell cycle, along with mitotic defects. In this report, we investigated the functional significance of the interaction b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210314

    authors: Buchsbaum S,Morris C,Bochard V,Jalinot P

    更新日期:2007-08-02 00:00:00

  • Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence.

    abstract::SOX5 is a member of the high-mobility group superfamily of architectural non-histone proteins involved in gene regulation and maintenance of chromatin structure in a wide variety of developmental processes. Sox5 was identified as a brain tumor locus in a retroviral insertional mutagenesis screen of platelet-derived gr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.9

    authors: Tchougounova E,Jiang Y,Bråsäter D,Lindberg N,Kastemar M,Asplund A,Westermark B,Uhrbom L

    更新日期:2009-03-26 00:00:00

  • The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor.

    abstract::The mixed lineage leukemia (MLL) gene at chromosome band 11q23 is commonly involved in reciprocal translocations that are detected in acute leukemias. Evidence suggests that the resulting MLL fusion genes contribute to leukemogenesis. AF9 is a common MLL fusion partner in acute myeloid leukemia. The AF9 protein functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206361

    authors: Srinivasan RS,de Erkenez AC,Hemenway CS

    更新日期:2003-05-29 00:00:00